跳至主要内容
临床试验/CTRI/2018/07/015021
CTRI/2018/07/015021进行中(未招募)2 期

Effectiveness of Palmitoyl Ascorbate in Managing Trigeminal Neuralgia (TN):A Cross-over Phase II Randomised Controlled Clinical Trial

Parkinsons Improvement Programme0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • The TN cases included will be based according to the international headache classification: paroxymal unilateral pain triggered in the anatomical region of the trigeminal nerve without any sensory ormotor focal symptoms in this region.

排除标准

  • Excluded from the study will be the patients with other neurological diseases, severe psychological diseases, serious chronic diseases, such as ischemic heart disease, pulmonary emphysema, and those with history of severe drug allergy. We also excluded patients treated with orally anaesthetics, allergy to vitamin C.

研究者

发起方
Parkinsons Improvement Programme

相似试验